Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

News | Robotic Systems

July 21, 2022 — Robocath, a company that designs, develops and commercializes innovative robotic platforms for the ...

Home July 22, 2022
Home
News | Drug-Eluting Balloons

July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon ...

Home July 12, 2022
Home
News | Drug-Eluting Balloons

June 8, 2022 — The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial ...

Home June 08, 2022
Home
News | Stents

June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the iCa ...

Home June 02, 2022
Home
Dr. Jeff Healey is seen implanting a subcutaneous defibrillator in a patient at the Electrophysiology Lab. Image credit: Owen Thomas, Hamilton Health Sciences.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of May ...

Home June 01, 2022
Home
News | Drug-Eluting Balloons

May 27, 2022 — Medtronic today announced approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT 018 ...

Home May 27, 2022
Home
News | Cardiovascular Business

May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific ...

Home May 16, 2022
Home
News | Drug-Eluting Balloons

March 31, 2022 — In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset ...

Home March 31, 2022
Home
News | Balloon Catheter

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...

Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
A new treatment to achieve return of spontaneous circulation (ROSC) in refractory cardiac arrest patients is the use of resuscitative endovascular balloon occlusion of the aorta (REBOA). The images show the balloon seen deployed on an angiogram and an illustration showing its placement in the aorta. 
Feature | Sudden Cardiac Arrest | By Adam Power, M.D.

Out-of-hospital cardiac arrest (OHCA) continues to be overwhelmingly fatal despite cardiopulmonary resuscitation (CPR) ...

Home January 14, 2022
Home
Subscribe Now